Invention Grant
- Patent Title: Single chain variable fragment CD3 binding proteins
-
Application No.: US16773806Application Date: 2020-01-27
-
Publication No.: US11623958B2Publication Date: 2023-04-11
- Inventor: Robert B. Dubridge , Pui Seto , Richard J. Austin , Luke Evnin , Jeanmarie Guenot , Bryan Lemon
- Applicant: Harpoon Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Harpoon Therapeutics, Inc.
- Current Assignee: Harpoon Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/18

Abstract:
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.
Public/Granted literature
- US20200231672A1 SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS Public/Granted day:2020-07-23
Information query